Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets - Takeaways - MDSpire

Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets

  • By

  • Ahmed Hassan

  • Amr Yosry Emam

  • Mina Samir

  • Kerolos Sobhy

  • Ihab Abd El Nabi

  • Hala Ali

  • Mohammed Thabet

  • Ahmed Elghazoly

  • Nagwa Thabet

  • Ahmed Elguindy

  • May 29, 2026

  • 0 min

Share

  • 1

    Residual inflammatory risk is prevalent after STEMI, even with optimal LDL-C management, as indicated by elevated hs-CRP levels.

  • 2

    In this study, 44.6% of patients had hs-CRP levels greater than 3 mg/L, highlighting significant ongoing inflammation.

  • 3

    Achieving secondary prevention targets, including waist circumference and LDL-C levels, correlates with lower hs-CRP levels.

  • 4

    Notably, 29.8% of patients with LDL-C < 55 mg/dL still exhibited elevated hs-CRP, indicating persistent inflammatory risk.

  • 5

    The findings emphasize the need for comprehensive strategies targeting inflammation alongside traditional cardiovascular risk factors.

Original Source(s)

Residual inflammatory risk post STEMI: high prevalence despite LDL-C control and association with other secondary prevention targets

  • by Ahmed Hassan, Amr Yosry Emam, Mina Samir, Kerolos Sobhy, Ihab Abd El Nabi, Hala Ali, Mohammed Thabet, Ahmed Elghazoly, Nagwa Thabet, Ahmed Elguindy

  • May 29, 2026

Related Content

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.

Risk factors of bleeding in patients with atrial fibrillation undergoing percutaneous coronary intervention: an analysis from the MANJUSRI study

Assessment of Safety and Efficacy of Varying Durations of Dual Antiplatelet Therapy with Aspirin and Ticagrelor Following Successful Percutaneous Coronary Intervention in Diabetic Patients with Acute Coronary Syndrome